NCCN 指南卵巢癌 输卵管癌 原发性腹膜癌指南1.2022 版.pdf,® NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Ovarian Cancer Including Fallopian Tube Cancer and Primary Peritoneal Cancer Version 1.2022 — January 18, 2022 NCCN.org ® NCC
6.MingelsMJ,vanHamMA,deKievitIM,etal.Müllerianprecursor lesions inserousovariancancerpatients:usingtheSEE-FimandContinuedonOV-A (4 of 4) SEE-End protocol. Mod Pathol 2014;27:1002-1013. OV-A,4/4 英文版 中文版 特殊情况 ●保留生育能力的手术: ►某些明显为早期和/或低危肿瘤(早期浸润性上皮性...
These are some of the highlights of the guidelines without analysis or commentary. For more information, go directly to the guidelines by clicking the link in the reference. September 29, 2022Updated guidelines on the diagnosis and treatment of ovarian cancer were published on September 10, 2022 ...
OV-2 ® ® ® Version1.2022,01/08/22©2022NationalComprehensiveCancerNetwork (NCCN ),Allrightsreserved.NCCNGuidelines andthisillustrationmaynotbereproducedinanyformwithouttheexpresswrittenpermissionofNCCN. 本指南由邱立新医生团队编译,仅供个人学习使用,严禁用于商业,请于下载后24小时删除。版权归©2022 ...
5.NCCN Guidelines Version 5.2022 Ovarian Cancer Continue Including Fallopian Tube Cancer and Primary Peritoneal Cancer. 作者:医世象 叶子,转载请联系授权。 携手抗癌 在与癌症的斗争过程是漫长并痛苦的。抗癌路上,与医生或者癌友之间的交流,可以给到患者或家属一些治疗的帮助和心灵的慰藉;我们建立了各个癌种的援助...
[13]Petrucelli N, et al. BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer. 1998 Sep 4 [updated 2022 May 26]. GeneReviews® [Internet]. [14]O’Connor MJ. Mol Cell,2015,60:547-560. [15]Iglehart ...
regarding sperm banking or oocyte, egg, or ovarian tissue banking, as appropriate, prior to treatment.UPDATES? ? ?Version 2.2022, 10/27/22 ? 2022 National Comprehensive Cancer Network (NCCN ), All rights reserved. NCCN Guidelines and this illustration may not be reproduced in any form without...
Middle pathway revised: Adjuvant chemotherapy followed by endocrine therapy± ovarian suppression/ablation(Also for bottom pathway) 新增脚注kk:对于激素受体阳性、HER2阴性、高风险乳腺癌患者,可以考虑术后两年阿贝西利联合内分泌治疗(参见列于BINV-K的资格标准)。对于同时...
(2022.V3)NCCN临床实践指南:结直肠癌筛查.pdf,NCCN Guidelines Version 3.2022 NCCN Guidelines Index Table of Contents Colorectal Cancer Screening Discussion NCCN Colorectal Cancer Screening Panel Members Clinical Trials: NCCN believes that Summary of the
Middle pathway revised: Adjuvant chemotherapy followed by endocrine therapy± ovarian suppression/ablation(Also for bottom pathway) 新增脚注kk:对于激素受体阳性、HER2阴性、高风险乳腺癌患者,可以考虑术后两年阿贝西利联合内分泌治疗(参见列于BINV-K的资格标准)。对于同时适合术后奥拉帕利和阿贝西利的患者,治疗最佳...